While this is a major formulation milestone, its real significance lies in how the oral GLP-1 pill changes the scalability, accessibility, and commercial architecture of obesity and cardiometabolic treatment
doi: 10.3389/fphar.2023.1303844 Received 28 September 2023 Accepted 30 November 2023 Published 11 December 2023 Volume 14 - 2023 Edited by Alessio Squassina, University of Cagliari, Italy Reviewed by Michele Mazzanti, University of Milan, Italy Yashmin Choudhury, Assam University, India Updates Copyright 2023 Greco, Coperchini, Croce, Magri, Teliti and Rotondi
Scientific References Frequently Asked Questions Can Ozempic cause weight gain instead of weight loss
Scarpino et al., 2005)
Administered weekly, Tirzepatide provides a convenient and effective solution for those struggling with obesity
Biochem., 106: 207-212